Furthermore, ChIP assays performed on clinical cervical cancer tissues (T1, T2 and T3, see Fig. 3) revealed significantly enhanced ZNF384 occupancy at the INTS13 promoter locus in contrast to adjacent paracancerous cervical tissues (N1, N2, and N3) (Fig. 9H). Here, ZNF384 is linked to cervical carcinoma.